These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2925239)

  • 21. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
    Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
    Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
    Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates.
    Johansson EL; Rask C; Fredriksson M; Eriksson K; Czerkinsky C; Holmgren J
    Infect Immun; 1998 Feb; 66(2):514-20. PubMed ID: 9453604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
    Menge AC; Michalek SM; Russell MW; Mestecky J
    Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term persistence and recall of immune responses in aged mice after mucosal immunization.
    Harrod T; Martin M; Russell MW
    Oral Microbiol Immunol; 2001 Jun; 16(3):170-7. PubMed ID: 11358539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin.
    Ohmura M; Yamamoto M; Kiyono H; Fujihashi K; Takeda Y; McGhee JR
    Vaccine; 2001 Dec; 20(5-6):756-62. PubMed ID: 11738739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.
    Migasena S; Pitisuttitham P; Suntharasamai P; Prayurahong B; Supanaranond W; Desakorn V; Black RE
    Infect Immun; 1989 Jul; 57(7):1942-5. PubMed ID: 2731977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit.
    Lycke N; Lindholm L; Holmgren J
    Int Arch Allergy Appl Immunol; 1983; 72(2):119-27. PubMed ID: 6874106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice.
    Kawabata S; Terao Y; Fujiwara T; Nakagawa I; Hamada S
    Infect Immun; 1999 Nov; 67(11):5863-8. PubMed ID: 10531241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
    Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
    J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization against experimental cholera: the role of antigen form and antigen combinations in evoking protection.
    Pierce NF; Cray WC; Sacci JB; Craig JP; Germanier R; Fürer E
    Ann N Y Acad Sci; 1983 Jun; 409():724-33. PubMed ID: 6603186
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
    J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization with dehydrated liposomes containing Streptococcus mutans glucosyltransferase (GTF) in humans.
    Childers NK; Zhang SS; Michalek SM
    Adv Exp Med Biol; 1995; 371B():1481-4. PubMed ID: 7502841
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses.
    Katz J; Michalek SM; Curtiss R; Harmon C; Richardson G; Mestecky J
    Adv Exp Med Biol; 1987; 216B():1741-7. PubMed ID: 3321939
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic responses to an oral liposome-Streptococcus mutans carbohydrate vaccine in humans.
    Childers NK; Michalek SM; Pritchard DG; McGhee JR
    Reg Immunol; 1990-1991; 3(6):289-96. PubMed ID: 2132755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
    Smith DJ; Lam A; Barnes LA; King WF; Peacock Z; Wise DL; Trantolo DJ; Taubman MA
    Oral Microbiol Immunol; 2003 Aug; 18(4):240-8. PubMed ID: 12823800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.